Target Price | HKD6.79 |
Price | HKD6.52 |
Potential |
4.19%
register free of charge
|
Number of Estimates | 24 |
24 Analysts have issued a price target CSPC Pharmaceutical Group Limited 2026 .
The average CSPC Pharmaceutical Group Limited target price is HKD6.79.
This is
4.19%
register free of charge
HKD13.93
113.59%
register free of charge
HKD4.77
26.82%
register free of charge
|
|
A rating was issued by 26 analysts: 17 Analysts recommend CSPC Pharmaceutical Group Limited to buy, 8 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CSPC Pharmaceutical Group Limited stock has an average upside potential 2026 of
4.19%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HKD | 31.45 | 33.33 |
7.76% | 5.96% | |
EBITDA Margin | 24.03% | 26.51% |
10.70% | 14.97% | |
Net Margin | 14.80% | 16.93% |
19.69% | 14.38% |
24 Analysts have issued a sales forecast CSPC Pharmaceutical Group Limited 2025 . The average CSPC Pharmaceutical Group Limited sales estimate is
This results in the following potential growth metrics:
12 CSPC Pharmaceutical Group Limited Analysts have issued a net profit forecast 2025. The average CSPC Pharmaceutical Group Limited net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HKD | 0.40 | 0.48 |
25.93% | 20.00% | |
P/E | 12.99 | |
EV/Sales | 1.97 |
12 Analysts have issued a CSPC Pharmaceutical Group Limited forecast for earnings per share. The average CSPC Pharmaceutical Group Limited EPS is
This results in the following potential growth metrics and future valuations:
CSPC Pharmaceutical Group Limited...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.